Glucose clamp technique: a method for quantifying insulin secretion and resistance

Author(s): DeFronzo RA, Tobin JD, Andres R

Abstract

Methods for the quantification of beta-cell sensitivity to glucose (hyperglycemic clamp technique) and of tissue sensitivity to insulin (euglycemic insulin clamp technique) are described. Hyperglycemic clamp technique. The plasma glucose concentration is acutely raised to 125 mg/dl above basal levels by a priming infusion of glucose. The desired hyperglycemic plateau is subsequently maintained by adjustment of a variable glucose infusion, based on the negative feedback principle. Because the plasma glucose concentration is held constant, the glucose infusion rate is an index of glucose metabolism. Under these conditions of constant hyperglycemia, the plasma insulin response is biphasic with an early burst of insulin release during the first 6 min followed by a gradually progressive increase in plasma insulin concentration. Euglycemic insulin clamp technique. The plasma insulin concentration is acutely raised and maintained at approximately 100 muU/ml by a prime-continuous infusion of insulin. The plasma glucose concentration is held constant at basal levels by a variable glucose infusion using the negative feedback principle. Under these steady-state conditions of euglycemia, the glucose infusion rate equals glucose uptake by all the tissues in the body and is therefore a measure of tissue sensitivity to exogenous insulin.

Similar Articles

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

Author(s): Cholesterol Treatment Trialists’ (CTT) Collaboration, Baigent C, Blackwell L, Emberson J, Holland LE, et al.

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Author(s): Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, et al.

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

Author(s): Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, et al.

Effects of pitavastatin on adiponectin in patients with hyperlipidemia

Author(s): Inami N, Nomura S, Shouzu A, Omoto S, Kimura Y, et al.

Beneficial direct adipotropic actions of pitavastatin in vitro and their manifestations in obese mice

Author(s): Ishihara Y, Ohmori K, Mizukawa M, Hasan AU, Noma T, et al.